Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Blood

• Publication date

  1997-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V89.3.814PMID 9028312
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors.

  1995cited by this paper
• Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.

  1995cited by this paper
• High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.

  1995cited by this paper
• Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy.

  1994cited by this paper
• Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.

  1994cited by this paper
• Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial.

  1993cited by this paper
• The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients.

  1993cited by this paper
• Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.

  1992cited by this paper
• Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.

  1991cited by this paper
• Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988

  1991cited by this paper
• Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988.

  1991cited by this paper
• Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.

  1991cited by this paper
• Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.

  1991cited by this paper
• Is there an effective salvage therapy for advanced Hodgkin's disease?

  1991cited by this paper
• High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.

  1990cited by this paper
• Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.

  1990cited by this paper
• A new Journal: why not?

  1990cited by this paper
• The treatment of metastatic breast cancer with adjuvant systemic therapy.

  1990cited by this paper
• Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation.

  1989cited by this paper
• Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).

  1988cited by this paper
• High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.

  1988cited by this paper
• High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease.

  1986cited by this paper
• MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.

  1985cited by this paper
• Marrow harvesting for autologous marrow transplantation.

  1985cited by this paper
• Prolonged initial remission in patients with nodular mixed lymphoma.

  1984cited by this paper
• Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.

  1984cited by this paper
• Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease.

  1982cited by this paper
• Prognostic factors in pathological stage IIIA Hodgkin's disease

  1980cited by this paper
• Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse.

  1979cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Combination chemotherapy in the treatment of advanced Hodgkin's disease.

  1970cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin’s lymphoma

  2024cites this paper
• Pattern of Recurrence After Platinum-Containing Definitive Therapy and Efficacy of Salvage Treatment for Recurrence in Patients with Squamous Cell Carcinoma of the Head and Neck

  2022cites this paper
• Successful brentuximab vedotin monotherapy against late relapse of classical Hodgkin lymphoma 6 years after first remission

  2020cites this paper
• Second autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma after a previous autograft: a study of the lymphoma working party of the EBMT

  2020cites this paper
• Comparison of survival between hodgkin and non-hodgkin lymphoma after autologous stem cell transplantation

  2020cites this paper
• Outcome predictors of autologous hematopoietic stem cell transplantation in children with relapsed and refractory Hodgkin lymphoma: Single‐center experience in a lower‐middle‐income country

  2019cites this paper
• High-dose therapy and autologous hematopoietic progenitor cells transplantation for relapsed or refractory hodgkin lymphoma: a follow up analysis of king hussein cancer center,results and prognostic variables

  2018cites this paper
• A Dose-escalation Study of Recombinant Human Interleukin-18 in Combination With Ofatumumab After Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma

  2018cites this paper
• Late relapse of Hodgkin's lymphoma - is it different in clinical characteristics and outcome?

  2017cites this paper
• Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma.

  2017cites this paper
• Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience.

  2017cites this paper
• First Report on Stem Cell Transplant From Iraq.

  2017cites this paper
• Dose-Modified Ifosfamide, Epirubicin, and Etoposide is a Safe and Effective Salvage Therapy with High Peripheral Blood Stem Cell Mobilization Capacity for Poorly Mobilized Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma Patients.

  2016cites this paper
• Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma

  2016cites this paper
• Granulopoiesis‐stimulating factors for preventing infections after autologous peripheral stem cell transplantation for lymphoma and multiple myeloma in adults

  2016cites this paper
• Hematopoietic Cell Transplantation for Hodgkin Disease

  2016cites this paper
• Role of Maintenance Therapy after High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Aggressive Lymphomas: A Systematic Review.

  2016cites this paper
• The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

  2015cites this paper
• Age over 55 Years at Diagnosis Increases Risk of Second Malignancies after Auto-Transplantation for Hodgkin's Lymphoma Patients

  2015cites this paper
• Improved outcomes after autologous bone marrow transplantation for children with relapsed or refractory Hodgkin lymphoma: twenty years experience at a single institution.

  2015cites this paper
• Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: A children's oncology group report

  2015cites this paper
• Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma

  2014cites this paper
• Classical Hodgkin’s lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant

  2013cites this paper
• Hodgkin lymphoma.

  2013cites this paper
• Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin’s lymphoma: outcome after high-dose chemotherapy and auto-SCT

  2013cites this paper
• Study Group Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Prognostic factors and treatment outcome in primary progressive

  2013cites this paper
• Linfoma de Hodgkin - Dificuldade no diagnóstico e falência de resposta ao tratamento: a propósito de um caso clínico

  2013cites this paper
• Hematopoietic progenitor cells transplantation for recurrent or refractory Hodgkin's lymphoma

  2013cites this paper
• Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey

  2013cites this paper
• Role of Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma

  2012cites this paper
• Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin’s lymphoma resistant to platinum-containing first-line salvage chemotherapy

  2012cites this paper
• Hodgkin Lymphoma in Children, Adolescents and Young Adults

  2012cites this paper
• Overview of the Lymphoid Neoplasms

  2012cites this paper
• Therapy for Relapsed and Refractory Pediatric Hodgkin Lymphoma

  2012cites this paper
• High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic Variables

  2012cites this paper
• Long‐term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphoma

  2012cites this paper
• Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE)

  2012influential citation
• Persistence of CD30 expression in Hodgkin lymphoma following brentuximab vedotin (SGN-35) treatment failure

  2012cites this paper
• Salvage Therapy for Relapsed and Refractory Hodgkin Lymphoma

  2011cites this paper
• Autologous stem-cell transplantation in Hodgkin's lymphoma: analysis of a therapeutic option Transplante autólogo de células-tronco em linfoma de Hodgkin: análise de uma opção terapêutica

  2011cites this paper
• Autologous stem-cell transplantation in Hodgkin's lymphoma: analysis of a therapeutic option.

  2011cites this paper
• Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma

  2011cites this paper
• Autotransplants f or H odgkin's D isease i n P atients N ever Achieving R emission: A R eport F rom t he A utologous B lood and M arrow T ransplant R egistry

  2011cites this paper
• Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin’s lymphoma

  2010cites this paper
• High-dose chemotherapy and autologous stem cell transplant in adolescent patients with relapsed or refractory Hodgkin's lymphoma

  2010cites this paper
• Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome.

  2010cites this paper
• A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy.

  2010cites this paper
• Human immunodeficiency and Hodgkin lymphoma.

  2010cites this paper
• Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience

  2010cites this paper
• Lymphoid Leukaemias of Mature T, B and Natural Killer Cells

  2010cites this paper
• High‐dose chemo‐radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre‐transplant functional imaging

  2010cites this paper
• Prognostication and Risk-Adapted Therapy of Hodgkin's Lymphoma Using Positron Emission Tomography

  2010cites this paper
• Transplante de clulas-tronco hematopoticas em linfoma Hodgkin

  2010cites this paper
• Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas

  2010influential citation
• Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution

  2010cites this paper
• Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma.

  2010cites this paper
• Standard therapy of advanced Hodgkin lymphoma.

  2009cites this paper
• The role of hematopoietic stem cell transplantation in Hodgkin lymphoma.

  2009cites this paper
• Does the addition of involved field radiotherapy to high-dose chemotherapy and stem cell transplantation improve outcomes for patients with relapsed/refractory Hodgkin lymphoma?

  2009cites this paper
• [Autologous stem cell transplantation in the treatment of Hodgkin's disease].

  2009cites this paper
• The principles and overview of autologous hematopoietic stem cell transplantation.

  2009cites this paper
• Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study.

  2009cites this paper
• Classical Hodgkin’s lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up

  2009cites this paper
• Hypertension Congestive heart failure Peripheral vascular disease Cerebrovascular disease Angina Cardiac arrhythmia Myocardial infarction

  2008cites this paper
• Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma

  2008cites this paper
• Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.

  2008cites this paper
• High-dose chemotherapy and autologous stem cell transplantation for Hodgkin's lymphoma in the kingdom of Saudi Arabia: King Faisal specialist hospital and research center experience

  2008cites this paper
• Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma

  2008cites this paper
• High‐dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma

  2008cites this paper
• Stem Cell Transplantation for Hodgkin's and Non-Hodgkin's Lymphomas

  2008cites this paper
• The relationship between absolute lymphocyte count with PFS in patients with Hodgkin's lymphoma undergoing autologous hematopoietic cell transplant

  2008cites this paper
• Two autologous transplants in the treatment of patients with Hodgkin's lymphoma: Analysis of prognostic factors and comparison with a single procedure

  2007cites this paper
• Treatment of refractory and relapsed Hodgkin's lymphoma: facts and perspectives.

  2007cites this paper
• Chapter 58 – Bone Marrow and Peripheral Blood Stem Cell Transplantation

  2007cites this paper
• Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma

  2007cites this paper
• Tandem high‐dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study

  2007cites this paper
• The autologous hematopoietic stem cell transplantation in adult patients with lymphoma : Turkish Bone Marrow Transplantation Registry results

  2007cites this paper
• Treatment of Relapsed/Refractory Hodgkin Lymphoma

  2007cites this paper
• Autologous stem cell transplantation for patients with active Hodgkin's lymphoma: Long-term outcome of 61 patients from a single institution

  2007cites this paper
• Relapsed and refractory Hodgkin's lymphoma: new avenues?

  2007cites this paper
• High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: Prognostic features and outcomes

  2007cites this paper
• Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients

  2007cites this paper
• Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma.

  2007cites this paper
• Ifosphamide, etoposide and epirubicin is an effective combined salvage and peripheral blood stem cell mobilisation regimen for transplant‐eligible patients with non‐Hodgkin lymphoma and Hodgkin disease

  2007cites this paper
• TO: ALL SOUTHWEST ONCOLOGY GROUP AND BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK APPROVED AUTOLOGOUS BONE MARROW TRANSPLANT FACILITIES (See Section 19.2 or 19.3, respectively)

  2007cites this paper
• A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma

  2006cites this paper
• Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease.

  2006cites this paper
• Prognostic impact of pretransplantation computed tomography and gallium scans in patients with Hodgkin lymphoma with poor prognosis undergoing hematopoietic stem cell transplantation.

  2006cites this paper
• Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.

  2006cites this paper
• Similar response rates and superior early progression‐free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma

  2006cites this paper
• Mitoxantrone, vinblastine and CCNU: long-term follow-up of patients treated for advanced and poor-prognosis Hodgkin's disease

  2006cites this paper
• Blood and bone marrow transplantation for patients with Hodgkin's and non-Hodgkin's lymphoma.

  2006cites this paper
• High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma

  2006cites this paper
• FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

  2006cites this paper
• Comparison of peripheral blood progenitor cell yield from standard chemotherapy used in the treatment of lymphoid malignancies and high‐dose cyclophosphamide: a retrospective review of 141 patients

  2006cites this paper
• ong-term Outcome of Hodgkin Disease Patients ollowing High-Dose Busulfan, Etoposide, yclophosphamide, and Autologous tem Cell Transplantation

  2006cites this paper
• Management of advanced stage Hodgkin's lymphoma.

  2006cites this paper
• Biologic Principles of Hematopoietic Stem Cell Transplantation

  2006cites this paper
• Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse.

  2005cites this paper
• Autologous transplantation followed closely by reduced-intensity allogeneic transplantation as consolidative immunotherapy in advanced lymphoma patients: a feasibility study

  2005cites this paper